World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
43
Citations
5571
World Ranking
5299
National Ranking
2013

Joshua T. Schiffer publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Joshua T. Schiffer sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 144 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Joshua T. Schiffer D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Joshua T. Schiffer sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 43 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Joshua T. Schiffer is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research focuses primarily on infectious diseases, epidemiology, modeling and simulation, virology, and immunology within the broader domain of medicine.

Their scholarly contributions include work on SARS-CoV-2 and COVID-19 research, COVID-19 epidemiological studies, HIV research and treatment, COVID-19 clinical research studies, HIV/AIDS drug development and treatment, cytomegalovirus and herpesvirus research, and herpesvirus infections and treatments.

Recent papers by Joshua T. Schiffer feature significant topics in virology and infectious disease management. These papers include:

  • Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients, 2021, published in New England Journal of Medicine
  • Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events, 2021, published in eLife
  • Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response, 2020, published in Science Advances
  • Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination, 2021, published in Nature Communications
  • Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation, 2021, published in Blood

Joshua T. Schiffer has frequently collaborated with several researchers, including Daniel B. Reeves, E. Fabián Cardozo-Ojeda, David A. Swan, Keith R. Jerome, and Peter B. Gilbert. These frequent co-authors indicate active participation in multidisciplinary research teams addressing viral infections and treatment strategies.

Their publications are commonly found in venues such as bioRxiv (Cold Spring Harbor Laboratory), Open Forum Infectious Diseases, Nature Communications, Journal of Clinical Investigation, and Viruses. This distribution reflects consistent contributions to both preprint platforms and peer-reviewed journals in infectious disease and immunology fields.

Best Publications

  • Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis

    Katharine J Looker;Jocelyn Elmes;Sami L Gottlieb;Joshua Schiffer;Joshua Schiffer

  • Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response.

    Ashish Goyal;E. Fabian Cardozo-Ojeda;Joshua T. Schiffer;Joshua T. Schiffer

  • Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events.

    Ashish Goyal;Daniel B Reeves;E Fabian Cardozo-Ojeda;Joshua T Schiffer

  • The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality.

    Joshua A. Hill;Bryan T. Mayer;Hu Xie;Wendy M. Leisenring

  • Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials

    Christine Johnston;Christine Johnston;Misty Saracino;Steve Kuntz;Amalia Magaret;Amalia Magaret

  • Rapid host immune response and viral dynamics in herpes simplex virus-2 infection

    Joshua T Schiffer;Lawrence Corey;Lawrence Corey

  • Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination.

    Laura Matrajt;Julia Eaton;Tiffany Leung;Dobromir Dimitrov;Dobromir Dimitrov

  • Rapid and profound shifts in the vaginal microbiota following antibiotic treatment for bacterial vaginosis

    Bryan T. Mayer;Sujatha Srinivasan;Tina L. Fiedler;Jeanne M. Marrazzo

  • A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation.

    Daniel B. Reeves;Elizabeth R. Duke;Elizabeth R. Duke;Thor A. Wagner;Sarah E. Palmer

  • Frequent Release of Low Amounts of Herpes Simplex Virus from Neurons: Results of a Mathematical Model

    Joshua T. Schiffer;Laith Abu-Raddad;Laith Abu-Raddad;Karen E. Mark;Karen E. Mark;Jia Zhu;Jia Zhu

  • Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes

    Joshua T. Schiffer;Laith Abu-Raddad;Karen E. Mark;Jia Zhu

  • AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication

    Nicholas D. Weber;Nicholas D. Weber;Daniel Stone;Ruth Hall Sedlak;Harshana S. De Silva Feelixge

  • Targeted DNA Mutagenesis for the Cure of Chronic Viral Infections

    Joshua T. Schiffer;Joshua T. Schiffer;Martine Aubert;Nicholas D. Weber;Nicholas D. Weber;Esther Mintzer;Esther Mintzer

  • Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation.

    Danniel Zamora;Danniel Zamora;Elizabeth R. Duke;Elizabeth R. Duke;Hu Xie;Bradley C. Edmison

  • Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS : A decision analysis

    Joshua T Schiffer;Timothy R Sterling

  • COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact.

    David A Swan;Chloe Bracis;Holly Janes;Mia Moore

  • Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation

    Joshua T. Schiffer;Kate Kirby;Brenda Sandmaier;Rainer Storb

  • A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir

    Claire N. Levy;Sean M. Hughes;Pavitra Roychoudhury;Daniel B. Reeves

  • Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding.

    Joshua T. Schiffer;Joshua T. Schiffer;Bryan T. Mayer;Youyi Fong;Youyi Fong;David A. Swan

  • New concepts in understanding genital herpes

    Joshua T. Schiffer;Lawrence Corey

  • Frequent Release of Low Amounts of Herpes Simplex

    Joshua T. Schiffer;Laith Abu-Raddad;Karen E. Mark;Jia Zhu

Frequent Co-Authors

Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
Keith R. Jerome
Keith R. Jerome Fred Hutchinson Cancer Research Center
Anna Wald
Anna Wald University of Washington
Amalia Magaret
Amalia Magaret University of Washington
Michael Boeckh
Michael Boeckh Fred Hutchinson Cancer Research Center
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
Alexander L. Greninger
Alexander L. Greninger University of Washington
Hans Peter Kiem
Hans Peter Kiem Fred Hutchinson Cancer Research Center
Morgane Rolland
Morgane Rolland Henry M. Jackson Foundation
Wendy Leisenring
Wendy Leisenring Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options after studying Microbiology in the USA opens several interdisciplinary opportunities, especially within healthcare and information management. For those interested in combining clinical knowledge with holistic care, becoming a Functional Medicine Nurse Practitioner is a growing path. You can learn more about the functional medicine np salary and career prospects to understand how this role leverages scientific and patient-centered approaches.

Microbiology graduates can also pivot into health information roles. Certified Professional Coders play a crucial part in medical documentation, billing, and insurance processes. Exploring the certified professional coder career path reveals opportunities for specialization in healthcare administration alongside scientific knowledge.

For those interested in managing healthcare data and technology systems, Health Information Management offers a promising career path. Investigate health information management jobs salary and roles to learn about how this field integrates technology with healthcare expertise, creating vital connections to patient outcomes and clinical services.

If you want to advance your credentials in this area, pursuing a cahiim accredited health information management degree online offers flexible education options recognized by employers, providing an excellent foundation for leadership roles in healthcare information management.

Best Scientists Citing Joshua T. Schiffer

Trending Scientists

Recently Published Articles